Twenty-Four Hour In-Hospital Congenital Cardiac Surgical Coverage Improves Perioperative ECMO Support Outcomes
The purpose of this study is to evaluate the effect of 24-hour in-hospital congenital cardiac surgical coverage (24-CCSC) on perioperative Extracorporeal membrane oxygenation (ECMO) outcomes in congenital heart surgery (CHS) patients.
Overview of Extracorporeal Membrane Oxygenation in Cardiogenic Shock
The purpose of this article was to review cardiogenic shock etiologies, the role of ECMO, and to discuss the transition process of implementing a nurse-run ECMO program.
Mechanical Circulatory Support in Acute Cardiogenic Shock
Percutaneous left ventricular assist devices such as TandemHeart® and Impella are easier to institute than ECMO and are better for hemodynamics compared with the IABP but also have not yet shown a mortality benefit.
The Impact of Vessel Clamps on Endothelial Integrity and Function of Saphenous Vein Grafts
The endothelial cells can be better preserved with short-term application of SVGs with metal clamps rather than plastic clamps.
Significance of Positive Mediastinal Cultures in Pediatric Cardiovascular Surgical Procedure Patients Undergoing Delayed Sternal Closure
Patients with positive mediastinal cultures obtained at DSC had a significantly higher rate of subsequent SSI
Double Bull’s Eye for Post-Operative Intravenous Iron in Patient Blood Management: Better Outcome and Cost-Effective
The results of this economic evaluation showed that iron-treated patients had a significantly lower allogeneic transfusion rate in comparison to control subjects
Cost of Post-Operative Intravenous Iron Therapy in Total Lower Limb Arthroplasty: A Retrospective, Matched Cohort Study
post-operative intravenous iron after total lower limb arthroplasty seems to be safe and is associated with reduced transfusion rates
New HTK-N46B Cardioplegia Provides Superior Protection During Ischemia/Reperfusion in Failing Hearts
The aim of this paper was to improve operative outcome during open-heart surgery in patients with failing hearts, the composition of cardioplegic solutions has to be further optimized.
Minimally Invasive Mitral Valve Surgery Using Single Dose Antegrade Custodiol Cardioplegia
Our unit began a minimally invasive mitral surgery (MIMS) program utilizing antegrade Custodiol solution as the sole cardioplegia. The aim of this paper is to report our results of this program.
Eight Hours of Cold Static Storage with Adenosine and Lidocaine (Adenocaine) Heart Preservation Solutions: Toward Therapeutic Suspended Animation
Our aim was to investigate the effects of 8 hours of cold static storage (4°C) using 2 normokalemic, polarizing adenosine-lidocaine (Adenocaine; Hibernation Therapeutics Global Ltd, Kilquade, Ireland) solutions and to compare their functional recovery with hearts preserved in gold standard histidine-tryptophan-ketoglutarate (Custodiol-HTK; Essential Pharma, Newtown, Pa) and Celsior (Genzyme, Cambridge, Mass) solutions.
Custodiol Versus Blood Cardioplegia in Complex Cardiac Operations: An Australian Experience
We hypothesized that a single administration of Bretschneider histidine-tryptophan-ketoglutarate (HTK) crystalloid solution (Custodiol) offers myocardial protection comparable with repeated tepid blood cardioplegia.
Review Inflammation Guideline (EP Video)
David C. Fitzgerald discusses the best practices with inflammation management during CPB (20:20 minutes).